Sarah’s Journey With ALK+ Metastatic NSCLC

Opinion
Video

A 55-year-old mom and high school teacher who received lorlatinib for ALK+ NSCLC with brain metastases.

Recent Videos
Anne M. Reb, PhD, NP, discussing a nurse-led intervention for fear of cancer recurrence.
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.